SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950116-01-500814
Filing Date
2001-09-14
Accepted
2001-09-14 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 424B3 four24b3.txt 424B3 60495
  Complete submission text file 0000950116-01-500814.txt   61906
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO M5J A1
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-67118 | Film No.: 1737216
SIC: 2834 Pharmaceutical Preparations